## Abstract ## Background For many applications, efficient gene therapy will require longβterm, organβspecific therapeutic gene expression. Lentiviral vectors based on HIVβ1 are promising gene delivery vehicles due to their ability to integrate transgenes into nonβdividing cells. Many experimental
Lentiviral vectors: optimization of packaging, transduction and gene expression
β Scribed by Christophe Delenda
- Book ID
- 102344618
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 283 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1099-498X
- DOI
- 10.1002/jgm.501
No coin nor oath required. For personal study only.
β¦ Synopsis
Gene transfer vectors based on retroviruses including oncogenic retroviruses and lentiviruses provide effective means for the delivery, integration and expression of exogenous genes in mammalian cells. Lentiviral (LV) vectors provide attractive gene delivery vehicles in the context of non-dividing cells. This review summarizes the different optimized LV genetic systems that have been developed to date. In all cases, the production of LV-derived vectors consists of a genetically split gene expression design. The viral elements that are specifically required are (i). the LV packaging helper proteins consisting of at least the gag-pol genes, (ii). the LV transfer vector RNA containing the transgene expression cassette, and (iii). an heterologous glycoprotein. While the genetic requirements and performances of the two former viral elements will be treated herein, the latter element relative to the envelope pseudotyping of LV vectors will not be further described (cf. review by Cosset in this issue).
π SIMILAR VOLUMES
## Abstract ## Background The potential of lentiviral vectors for clinical gene therapy has not yet been evaluated. One of the reasons is the cytotoxicity of lentiviral packaging genes which makes the generation of stable producer cell lines difficult. Therefore, a novel packaging system for lenti